Sundhedssektoren dækker alt fra forskning over medicin til sundhedssystemer. Sektoren kan opdeles i to kategorier: “Health Care Equipment and Services” - også kaldet “medico” - og “Pharmaceuticals, Biotechnology & Life Sciences”. Medicoindustrien består af selskaber, der udvikler, producerer og sælger medicinsk udstyr, mens “Pharmaceuticals, Biotechnology & Life Sciences”-kategorien består af store medicinalvirksomheder og biotekvirksomheder, der producerer forskellige former for lægemidler og medicinalvarer. I Danmark har vi en særligt veludviklet medicinalindustri med mange børsnoterede virksomheder, der både er veldrevne og sunde. Sundhedssektoren rummer store investeringsmuligheder, uanset om man er til defensive, langsigtede og sikre selskaber eller de nye og mere risikable selskaber med stort kurspotentiale.
Regnet på de 227 aktier i listen — som percentiler målt mod alle de aktier vi følger, ikke som karakterer. Genberegnes hver dag efter børslukning.
Hvad tallene siger i dag: Kvalitet: middel · Værdi: lav · Momentum: middel — målt som percentiler mod alle de aktier vi følger, ikke som karakterer. Flertallet af aktierne handler over deres egne gennemsnit lige nu. Spændet er stort — momentum går fra 0 til 99, så gennemsnittet dækker over meget forskellige selskaber.
| Aktie | Land | Kurs | Ændring |
|---|---|---|---|
| Tenet Healthcare Corporation | USA | 286,03 | -0,29% |
| H Lundbeck A/S | Danmark | 58,20 | +2,28% |
| Amphastar P | USA | 29,37 | +1,73% |
| H Lundbeck A/S | Danmark | 59,35 | +1,02% |
| Bavarian Nordic A/S | Danmark | 237,20 | -1,08% |
| Humana AB (publ) | Sverige | 70,90 | +0,42% |
| Arjo AB (publ) | Sverige | 36,56 | +0,83% |
| Bristol-Myers Squibb Company | USA | 63,43 | +1,78% |
| Regeneron Pharmaceuticals, Inc | USA | 955,47 | +0,45% |
| Orion Oyj | Finland | 103,00 | +0,29% |
| Sanofi ADR | USA | 48,37 | -0,19% |
| Synsam AB | Sverige | 62,70 | +1,13% |
| Medtronic plc | USA | 102,86 | 0,00% |
| Cigna Corporation | USA | 297,00 | 0,00% |
| Siemens Healthineers AG | Tyskland | 43,95 | +0,34% |
| Ascendis Pharma A/S | USA | 275,39 | +3,12% |
| Ambea AB | Sverige | 195,50 | +0,51% |
| Universal Health Services, Inc | USA | 194,07 | +0,12% |
| Novo Nordisk A/S | USA | 41,51 | +2,12% |
| UCB SA | Belgien | 296,50 | +0,44% |
| Amgen Inc | USA | 465,37 | -0,36% |
| Drägerwerk AG & Co. KGaA | Tyskland | 110,60 | +0,36% |
| Attendo AB (publ) | Sverige | 132,70 | +0,68% |
| QIAGEN N.V | USA | 49,89 | -0,42% |
| Drägerwerk AG & Co. KGaA | Tyskland | 82,80 | -0,72% |
| CVS Health Corporation | USA | 89,35 | -0,49% |
| Novo Nordisk A/S | Danmark | 278,45 | +0,98% |
| Fresenius Medical Care AG & Co. KGaA | Tyskland | 40,11 | +1,39% |
| Royalty Pharma plc | USA | 69,31 | +0,49% |
| CellaVision AB | Sverige | 203,50 | +0,74% |
| Eton Pharmaceuticals, Inc | USA | 63,93 | +4,04% |
| UnitedHealth Group Incorporated | USA | 407,46 | +0,58% |
| Merck KGaA | Tyskland | 149,60 | +0,98% |
| Eli Lilly and Company | USA | 1.445,42 | +1,27% |
| Getinge AB ser. B | Sverige | 281,60 | +0,57% |
| ChemoMetec A/S | Danmark | 688,50 | +0,51% |
| Demant A/S | Danmark | 350,20 | +3,18% |
| Centene Corporation | USA | 71,27 | +1,42% |
| McKesson Corporation | USA | 1.102,81 | 0,00% |
| Viatris Inc | USA | 20,82 | +0,73% |
| Camurus AB | Sverige | 745,00 | +0,81% |
| Swedish Orphan Biovitrum AB (publ) | Sverige | 474,20 | -2,63% |
| IQVIA Holdings Inc | USA | 265,12 | 0,00% |
| Pfizer Inc | USA | 28,89 | +0,22% |
| Haleon PLC | Storbritannien | 344,80 | +1,06% |
| Cantargia AB | Sverige | 1,39 | -0,93% |
| Ambu A/S | Danmark | 91,65 | +5,04% |
| Humana Inc | USA | 450,00 | 0,00% |
| AstraZeneca PLC | Storbritannien | 13.982,00 | +0,37% |
| Roche Holding AG | Schweiz | 321,50 | +0,25% |
| Bonesupport Holding AB | Sverige | 321,20 | +1,39% |
| Novartis AG | USA | 160,50 | 0,00% |
| Zealand Pharma A/S | Danmark | 242,00 | +0,37% |
| AstraZeneca PLC | Sverige | 1.866,00 | +0,97% |
| Biogen Inc | Tyskland | 166,36 | +2,98% |
| AbbVie Inc | USA | 295,03 | +0,20% |
| Danaher Corporation | USA | 233,02 | +0,37% |
| Johnson & Johnson | USA | 286,00 | +0,87% |
| Thermo Fisher Scientific Inc | USA | 700,22 | +0,11% |
| Convatec Group Plc | Storbritannien | 258,20 | +0,94% |
| Laboratorios Farmaceuticos Rovi, S.A | Spanien | 69,20 | -1,35% |
| Henry Schein, Inc | USA | 86,22 | 0,00% |
| InMode Ltd | USA | 13,27 | 0,00% |
| BeiGene, Ltd. | USA | 416,54 | +0,14% |
| Agilent Technologies, Inc | USA | 173,96 | +0,55% |
| Globus Medical, Inc | USA | 72,14 | 0,00% |
| Teva Pharma Industries Ltd ADR | USA | 44,50 | +1,95% |
| HCA Healthcare, Inc | USA | 499,05 | 0,00% |
| argenx SE | Belgien | 878,40 | -0,92% |
| Cardinal Health, Inc | USA | 281,10 | 0,00% |
| ALK-Abelló A/S | Danmark | 248,40 | -0,16% |
| Coloplast A/S | Danmark | 508,00 | +2,81% |
| Veeva Systems Inc | USA | 301,53 | -0,29% |
| SCHOTT Pharma AG & Co. KGaA | Tyskland | 22,30 | 0,00% |
| Biogen Inc | USA | 253,40 | 0,00% |
| TG Therapeutics, Inc | USA | 64,51 | -0,08% |
| DaVita HealthCare Partners Inc | USA | 174,56 | 0,00% |
| Halozyme Therapeutics, Inc | USA | 99,99 | -0,68% |
| Genmab A/S | Danmark | 3.448,00 | -2,32% |
| BioGaia AB (publ) | Sverige | 126,30 | +0,56% |
| Alcon Inc | USA | 74,12 | 0,00% |
| argenx SE | USA | 960,04 | 0,00% |
| ICON PLC | USA | 194,65 | -2,92% |
| Xeris Pharmaceuticals, Inc | USA | 16,66 | +0,06% |
| DaVita Inc. | Storbritannien | 173,94 | -1,40% |
| GN Store Nord A/S | Danmark | 119,35 | -2,13% |
| Bayer AG NA | Tyskland | 56,52 | -0,07% |
| Gerresheimer AG | Tyskland | 31,40 | -2,00% |
| Gilead Sciences, Inc | USA | 168,08 | 0,00% |
| Vertex Pharmaceuticals Incorporated | USA | 538,60 | -0,74% |
| Teladoc Inc | USA | 8,80 | +1,27% |
| Uniphar plc | Irland | 4,29 | -1,61% |
| Merck & Co., Inc | USA | 147,80 | +0,58% |
| Elekta AB (publ) | Sverige | 62,40 | +1,38% |
| Almirall, S.A | Spanien | 10,68 | -0,93% |
| Sprint Bioscience AB | Sverige | 3,87 | +2,38% |
| Carl Zeiss Meditec AG | Tyskland | 33,84 | -2,08% |
| Tactile Systems Technology, Inc | USA | 26,81 | -0,04% |
| Embla Medical hf | Danmark | 28,10 | +0,72% |
| Sectra AB (publ) | Sverige | 321,80 | +1,32% |
| Krystal Biotech, Inc | USA | 305,23 | 0,00% |
| Intuitive Surgical, Inc | USA | 443,59 | +0,84% |
| Bruker Corporation | USA | 61,59 | 0,00% |
| Dynavox Group | Sverige | 75,15 | +1,90% |
| Harvard Bioscience, Inc | USA | 9,39 | +1,90% |
| Paxman AB | Sverige | 67,50 | +8,00% |
| Abbott Laboratories | USA | 108,52 | +1,18% |
| Boston Scientific Corporation | USA | 44,34 | 0,00% |
| Illumina, Inc | USA | 207,01 | 0,00% |
| Photocure ASA | Norge | 42,85 | +2,27% |
| Aurora Cannabis Inc | USA | 4,86 | -2,58% |
| RaySearch Laboratories AB (publ) | Sverige | 179,30 | +1,88% |
| Asker Healthcare Group AB | Tyskland | 6,57 | -0,30% |
| Swedencare publ AB | Sverige | 19,92 | +2,15% |
| Insulet Corporation | USA | 152,48 | +2,14% |
| Ottobock SE & Co. KGaA | Tyskland | 40,05 | +2,17% |
| Omeros Corporation | USA | 17,49 | -2,78% |
| BrainCool AB | Sverige | 1,15 | +2,14% |
| BioMarin Pharmaceutical Inc | USA | 57,23 | 0,00% |
| ArcticZymes Technologies ASA | Norge | 21,60 | -4,85% |
| Vitrolife AB | Sverige | 119,20 | +1,19% |
| Sagimet Biosciences Inc. Series A Common Stock | USA | 10,22 | -6,50% |
| Moderna, Inc | USA | 222,25 | -3,93% |
| BICO Group AB | Sverige | 16,70 | +0,36% |
| Hansa Biopharma AB | Sverige | 46,84 | +1,21% |
| Sarepta Therapeutics, Inc | USA | 16,07 | +0,37% |
| Revenio Group Oyj | Finland | 9,27 | +3,00% |
| BioArctic AB (publ) | Sverige | 310,00 | -1,02% |
| Saniona AB | Sverige | 11,91 | +0,59% |
| Scandinavian Medical Solutions A/S | Danmark | 2,65 | +5,16% |
| Tempus AI, Inc. Class A Common Stock | USA | 71,60 | -5,65% |
| GRAIL, LLC | USA | 115,89 | -4,50% |
| Personalis, Inc | USA | 15,71 | -0,95% |
| AbCellera Biologics Inc | USA | 11,49 | 0,00% |
| Pharma Equity Group A/S Cl A | Danmark | 0,07 | 0,00% |
| Zomedica Corp. | USA | 0,10 | -1,02% |
| So-Young International Inc | USA | 2,02 | +4,12% |
| Nanexa AB | Sverige | 10,08 | +1,61% |
| Moberg Pharma AB (publ) | Sverige | 10,68 | +2,89% |
| Tilray, Inc | USA | 2,43 | -2,41% |
| CG Oncology Inc. Common stock | USA | 74,40 | +6,06% |
| BioNTech SE | USA | 85,60 | 0,00% |
| Vir Biotechnology, Inc | USA | 9,96 | -17,82% |
| Galmed Pharmaceuticals Ltd | USA | 2,48 | +3,77% |
| Canopy Growth Corporation | USA | 0,57 | -0,92% |
| Geron Corporation | USA | 0,97 | -2,72% |
| Filana Therapeutics, Inc. | USA | 0,43 | -5,11% |
| BioPorto A/S | Danmark | 1,00 | -0,90% |
| Infant Bacterial Therapeutics AB (publ) | Sverige | 66,00 | -9,96% |
| Revolution Medicines, Inc | USA | 172,29 | -2,30% |
| Dianthus Therapeutics Inc. | USA | 91,81 | -0,72% |
| GH RESEARCH PLC DL-025 | Tyskland | 17,50 | +5,42% |
| Century Therapeutics, Inc. Common Stock | USA | 1,65 | +1,23% |
| Circio Holding ASA | Norge | 9,36 | +0,54% |
| Alvotech SDB | Sverige | 43,70 | -4,79% |
| Cybin Inc. Common Stock | USA | 8,87 | +0,11% |
| Nano-X Imaging Ltd | USA | 0,33 | +3,17% |
| Palatin Technologies, Inc | USA | 6,23 | -5,18% |
| Iovance Biotherapeutics, Inc | USA | 7,80 | +2,23% |
| Novavax, Inc | USA | 8,50 | -2,97% |
| Acrivon Therapeutics Inc. Common Stock | USA | 1,45 | -0,68% |
| ExpreS2ion Biotech Holding AB | Sverige | 0,99 | +3,13% |
| PDS Biotechnology Corporation | USA | 0,87 | -10,96% |
| Viking Therapeutics, Inc | USA | 29,22 | +5,95% |
| GH Research PLC | USA | 19,10 | +3,30% |
| Immunic, Inc | USA | 7,52 | -3,47% |
| Recursion Pharmaceuticals, Inc | USA | 3,19 | -4,35% |
| Pila Pharma AB | Sverige | 1,67 | -1,76% |
| Beam Therapeutics Inc | USA | 23,04 | -4,13% |
| Denali Therapeutics Inc | USA | 18,74 | 0,00% |
| Heron Therapeuti | USA | 0,31 | -4,73% |
| Mendus AB (publ) | Sverige | 4,36 | -3,01% |
| Evaxion Biotech A/S | USA | 2,74 | -1,08% |
| Arcturus Therapeutics Holdings Inc | USA | 8,36 | -0,95% |
| Butterfly Network, Inc. | USA | 6,08 | 0,00% |
| CRISPR Therapeutics AG | USA | 42,17 | -1,06% |
| StenoCare A/S | Danmark | 0,67 | +2,13% |
| Initiator Pharma A/S | Sverige | 2,27 | -1,30% |
| Gubra A/S | Danmark | 302,40 | -0,40% |
| Monsenso A/S | Danmark | 0,19 | -3,61% |
| Anavex Life Sciences Corp | USA | 0,93 | 0,00% |
| Editas Medicine, Inc | USA | 2,17 | +2,84% |
| Co-Diagnostics, Inc | USA | 0,26 | 0,00% |
| SoftOx Solutions AS | Norge | 0,10 | +0,40% |
| Corbus Pharmaceuticals Holdings, Inc | USA | 3,39 | 0,00% |
| COMPASS Pathways plc | USA | 9,01 | -1,21% |
| Q linea AB | Sverige | 13,20 | -0,38% |
| XSpray Pharma AB | Sverige | 11,02 | -2,31% |
| AC Immune SA | USA | 2,13 | -0,47% |
| BioInvent International AB | Sverige | 2,92 | -0,17% |
| Axsome Therapeutics, Inc | USA | 141,69 | 0,00% |
| Fate Therapeutics, Inc | USA | 1,28 | -4,48% |
| Structure Therapeutics Inc. American Depositary Shares | USA | 20,00 | +0,81% |
| Autolus Therapeutics plc | USA | 1,17 | 0,00% |
| ViroGates A/S | Danmark | 7,10 | -6,58% |
| Thor Medical ASA | Norge | 4,06 | -0,98% |
| Acarix A/S | Sverige | 0,18 | +2,82% |
| Capricor Therapeutics, Inc | USA | 9,53 | -6,93% |
| Inovio Pharmaceuticals, Inc | USA | 1,42 | -2,74% |
| Summit Therapeutics Inc | USA | 14,15 | -6,14% |
| Arrowhead Pharmaceuticals, Inc | USA | 47,78 | 0,00% |
| Valerio Therapeutics | Frankrig | 0,43 | 0,00% |
| Sana Biotechnology, Inc | USA | 2,02 | +0,50% |
| Fluoguide AS | Sverige | 29,30 | +0,34% |
| SpectraCure AB | Sverige | 0,01 | -13,84% |
| Bullfrog AI Holdings, Inc. Common Stock | USA | 0,54 | -2,08% |
| Altimmune, Inc | USA | 1,65 | +2,17% |
| Immunitybio Inc | USA | 6,02 | -0,82% |
| Alzinova AB | Sverige | 0,32 | -0,16% |
| AIM ImmunoTech Inc | USA | 0,14 | -3,23% |
| Gossamer Bio, Inc | USA | 10,90 | -3,02% |
| Tenaya Therapeutics Inc. Common Stock | USA | 0,35 | +0,49% |
| DBV Technologies S.A | Frankrig | 1,97 | -0,15% |
| Northwest Biotherapeutics, Inc | USA | 0,16 | -7,39% |
| Biomea Fusion, Inc | USA | 0,58 | +3,47% |
| Oncopeptides AB | Sverige | 1,77 | +1,14% |
| Cardiff Oncology, Inc | USA | 0,73 | -0,21% |
| Faron Pharmaceuticals Oy | Finland | 0,36 | +3,00% |
| Xintela AB | Sverige | 0,14 | 0,00% |
| Passage Bio, Inc | USA | 4,25 | +5,99% |
| Lifecare AS | Norge | 0,38 | -1,68% |
| Ocugen, Inc | USA | 0,83 | -5,22% |
| 2cureX AB | Sverige | 0,42 | -12,13% |
| Qlife Holding AB | Sverige | 1,00 | +2,04% |
| Aptevo Therapeutics Inc | USA | 0,59 | -10,00% |
| Xeris Biopharma Holdings, Inc. | Storbritannien | 16,43 | -0,80% |
| CRISPR Therapeutics AG | Storbritannien | 42,20 | -2,02% |